Want to join the conversation?
$AON's operating expenses for 3Q15 fell 5% to $2.3Bil from last year. The fall was due to $162MM favorable impact from foreign currency exchange rates, $12MM decline in intangible asset amortization, and $5MM fall in expenses relates to acquisitions, net of divestitures, partially offset by rise in expense to support organic growth.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.